These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3703301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Kearns-Sayre syndrome. A case report.
    Altunbaşak S, Bingöl G, Ozbarlas N, Akçören Z, Hergüner O.
    Turk J Pediatr; 1998; 40(2):255-9. PubMed ID: 9677732
    [Abstract] [Full Text] [Related]

  • 5. Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients.
    Bresolin N, Bet L, Ferrante C, Binda A, Carenzi A, Moggio M, Comi G, Scarlato G.
    Adv Neurol; 1988; 48():239-56. PubMed ID: 3334786
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of Kearns-Sayre syndrome with coenzyme Q10.
    Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahashi M, Hashimoto S, Kono N, Tarui S.
    Neurology; 1986 Jan; 36(1):45-53. PubMed ID: 3941783
    [Abstract] [Full Text] [Related]

  • 7. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome.
    Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T, Nakamura Y, Hashimoto S, Kono N, Tarui S.
    Neurology; 1985 Mar; 35(3):372-7. PubMed ID: 3974895
    [Abstract] [Full Text] [Related]

  • 8. Steroid danger in Kearns-Sayre syndrome (KSS).
    Feinsmith BM, Liebesman WP, Guibor P.
    N J Med; 1988 Aug; 85(8):659-63. PubMed ID: 3050623
    [No Abstract] [Full Text] [Related]

  • 9. Kearns-Sayre syndrome presenting as 2-oxoadipic aciduria.
    Barshop BA, Nyhan WL, Naviaux RK, McGowan KA, Friedlander M, Haas RH.
    Mol Genet Metab; 2000 Jan; 69(1):64-8. PubMed ID: 10655159
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kearns-Sayre syndrome presenting as renal tubular acidosis.
    Eviatar L, Shanske S, Gauthier B, Abrams C, Maytal J, Slavin M, Valderrama E, DiMauro S.
    Neurology; 1990 Nov; 40(11):1761-3. PubMed ID: 2234434
    [Abstract] [Full Text] [Related]

  • 13. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10.
    Bresolin N, Bet L, Binda A, Moggio M, Comi G, Nador F, Ferrante C, Carenzi A, Scarlato G.
    Neurology; 1988 Jun; 38(6):892-9. PubMed ID: 3368070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate.
    Allen RJ, DiMauro S, Coulter DL, Papadimitriou A, Rothenberg SP.
    Ann Neurol; 1983 Jun; 13(6):679-82. PubMed ID: 6881930
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kearns-Sayre syndrome.
    Boraz RA.
    J Pedod; 1989 Jun; 13(4):373-7. PubMed ID: 2534699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.